Two years after revamping its developer programs and pricing, X is expanding the closed beta of a pay-per-use plan for its API to more developers. The social network is accepting applications from ...
Automaker Maruti Suzuki India has partnered with the Tamil Nadu government to automate driving testing tracks, enhancing transparency, efficiency, and safety. The initiative, part of Maruti's CSR ...
Tamil Nadu plans to complete key projects under the Defence Testing Infrastructure Scheme by December 2025. These projects aim to boost the state's defence industrial corridor, involving facilities ...
API testing is a critical part of modern software development, ensuring that digital services remain secure, reliable, and fast. As APIs grow ever more vital across cloud, mobile, enterprise, and ...
Rama Mallika Kadali is a QA Automation Test Lead with over 15 years of experience in software testing and automation. Rama Mallika Kadali is a QA Automation Test Lead with over 15 years of experience ...
Abstract: Regression testing of software systems is an important and critical activity yet expensive and resource-intensive. An approach to enhance its efficiency is Regression Test Selection (RTS), ...
Cybersecurity company Snyk Ltd. today announced the launch of Snyk API & Web, a new dynamic application security testing or DAST solution designed to meet the growing demands of modern and ...
DISCLAIMER: We use Google Analytics for sending anonymous usage information such as agent's and client's names, and their versions after a successful launch start. This information might help us to ...
OpenAI says that it won’t bring the AI model powering deep research, its in-depth research tool, to its developer API while it figures out how to better assess the risks of AI convincing people to act ...
Abstract: The development of RESTful APIs as modern web services needs a testing to ensure their reliability and performance. Postman has established itself as a premier tool for API development and ...
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. have landed in the FDA’s crosshairs thanks to quality shortfalls, poor testing standards ...